Effect of Comorbidity on Lung Cancer Diagnosis Timing and Mortality: A Nationwide Population-Based Cohort Study in Taiwan

Table 2

Characteristics of lung cancer death subjects between 1995 and 2010 (n =86,990).

Comorbidity	With comorbidity		Without comorbidity		p-value
Characteristics	(N=38,608)		(N=48,382)
	No.		No.
Gender					< 0.0001
Female	12,019	31.13%	13,924	28.78%
Male	26,589	68.87%	34,458	71.22%
Period of diagnosis (years)					0. 0018
1995-2000	7,204	18.66%	9,383	19.40%
2001-2005	13,752	35.62%	17,412	35.99%
2006-2010	17,652	45.72%	21,587	44.62%
Diagnostic age (yrs)					< 0.0001
<=39	436	1.13%	1,552	3.21%
40-49	1,537	3.98%	4,842	10.01%
50-59	4,387	11.36%	9,225	19.07%
60-69	8,835	22.88%	11,969	24.74%
>=70	23,413	60.64%	20,794	42.98%
Urbanization level					< 0.0001
1	12,742	33.00%	17,476	36.12%
2	20,216	52.36%	25,304	52.30%
3	3,607	9.34%	3,701	7.65%
4	1,491	3.86%	1,456	3.01%
5	552	1.43%	445	0.92%
Geographic region					< 0.0001
Central	9,784	25.34%	10,581	21.87%
Northern	17,398	45.06%	23,064	47.67%
Eastern	903	2.34%	842	1.74%
Southern	10,483	27.15%	13,837	28.60%
Islands	40	0.10%	58	0.12%

May not total 100% due to rounding. ().